Intellectual Property
GyreOx has protected its proprietary technology with four families of patent applications, with some now granted, covering both rationally engineered enzymes and the gyrocycle production process.
  • “In vitro production of cyclic peptides” (WO2014/001822, priority date June 2012) granted in Australia, USA and Europe
  • "Modified heterocyclase” (WO2016/071422, priority date November 2014), accepted for grant in the USA and in the national phase in Europe
  • "Macrocyclisation tags” (WO2019/048634, priority date September 2017) 
  • A further application to protect the technology enabling the transfer of resin-bound intermediates from organic to aqueous phase was filed in April 2019